查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404815

肝病診斷市場規模、佔有率、趨勢分析報告：按診斷技術、最終用途、地區、細分市場預測，2023-2030 年

Liver Disease Diagnostics Market Size, Share & Trends Analysis Report By Diagnosis Technique (Imaging, Laboratory Tests, Endoscopy, Biopsy, Others), By End-use (Hospitals, Laboratories, Others), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

肝病診斷市場成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，預計 2030 年全球肝病診斷市場規模將達到 586.2 億美元，2023 年至 2030 年複合年成長率為 6.5%。

市場參與者採取的資金籌措和研究舉措的增加是預計推動市場成長的主要因素之一。例如，2019年11月，Glycotest, Inc.獲得上海復星醫藥股份有限公司（復星醫藥）第二筆300萬美元1000萬美元A輪資金籌措。透過這項投資， Glico將把其肝癌組合技術轉移給佛山醫藥，在中國進行商業化，並開發目前正在研發中的肝癌和肝纖維化測試。

公司正專注於合作研究和合作夥伴關係，以提高醫療保健質量，預計這將推動市場發展。例如，2019 年 10 月，Perspectum Diagnostics 建立合作夥伴關係，在新加坡 Precious 醫療中心提供 LiverMultiScan。此次合作的目的是提高人們的認知，將肝臟檢查作為健康檢查的一個組成部分。

支持開發能夠準確區分良性和惡性病變的新診斷方法的研究和開發預計將推動市場成長。例如，柏林 Charite-Universitatsmedizin 的研究人員使用斷層彈性成像技術可視化腫瘤的機械特性，並使用新的磁振造影(MRI) 技術來檢測腫瘤的一致性分級。

此外，該公司還進行臨床試驗以開發具有高靈敏度和特異性的新測試。例如，高級醫學研究所正在進行一項臨床試驗，對 1,600 名超音波患者進行侵入性切片檢查與 cfDNA 甲基化定量與超音波檢查進行比較。此次檢查預計2020年完成。

準確診斷的開拓和商業化預計將推動市場發展。例如，2020 年 3 月，ENDRA Life Sciences Inc. 的 TAEUS FLIP 系統獲得了 CE 標誌。此系統測量肝臟脂肪，以識別和監測非酒精性脂肪肝病 (NAFLD) 和非酒精性脂肪性肝炎 (NASH)。一種可在照護端準確量化肝臟脂肪的超音波系統。

肝病診斷市場報告亮點

  • 診斷成像領域佔據最大的收益佔有率佔有率，預計將以最快的複合年成長率成長。這是由於肝病診斷市場的主要企業採取了一系列舉措來開發先進的診斷影像技術。
  • 到 2022 年，醫院部門將佔據最大的銷售佔有率，約為 45%，因為大多數患者都使用擁有設備齊全的診斷測試設備的醫院。
  • 北美將主導市場，到 2022 年將佔據最大的銷售佔有率，超過 40%，其次是歐洲。研發的高投資和主要參與者的存在預計將成為推動該地區肝病診斷市場成長的因素。
  • 預計亞太地區在預測期內將以 8.6% 的複合年成長率成長最快。老年人口的增加和對定期檢查的認知正在促進該地區肝病診斷市場的成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章肝病診斷市場的變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 肝病診斷市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 肝病診斷：診斷技術評估及趨勢分析

  • 肝病診斷市場：要點
  • 肝病診斷市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 影像
  • 臨床檢查
  • 內視鏡檢查
  • 切片檢查
  • 其他

第5章肝病診斷：最終用途估計與趨勢分析

  • 肝病診斷市場：要點
  • 肝病診斷市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 醫院
  • 實驗室
  • 其他

第6章 肝病診斷市場：區域估算及趨勢分析

  • 區域展望
  • 按地區分類的肝病診斷市場：要點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第7章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Randox Laboratories Ltd.
    • Boston Scientific Corporation
    • Laboratory Corporation of America Holdings
    • Fujifilm Corporation
    • Horiba Medical
    • Siemens Healthcare GmbH
Product Code: GVR-4-68038-693-6

Liver Disease Diagnostics Market Growth & Trends:

The global liver disease diagnostics market size is expected to reach USD 58.62 billion by 2030, expanding at a CAGR of 6.5% from 2023 to 2030, according to a new report by Grand View Research, Inc. increasing funding and research initiatives undertaken by market players is one of the major factors expected to propel market growth. For instance, in November 2019, Glycotest, Inc. received the second USD 3.0 million tranche of USD 10.0 million Series A funding from Shanghai Fosun Pharmaceutical Co., Ltd.(Fosun Pharma). Under this investment, Glycotest, Inc. transferred HCC panel technology to Fosun Pharma to commercialize in China and develop tests for liver cancer and liver fibrosis that are currently under pipeline.

Companies are focusing on collaborations and partnership to improve the quality of care,which is anticipated to drive the market. For instance, in October 2019, Perspectum Diagnostics entered into a partnership to offer LiverMultiScan at Precious Medical Center in Singapore. The aim of this partnership was to create awareness among people to consider liver checking as an integral part of their health screening.

Researchers conducting studies to support the development of novel diagnostic methods that can accurately differentiate between benign and malignant lesions are expected to fuel market growth. For instance, researchers from Charite - Universitatsmedizin Berlin used tomoelastography to visualize mechanical properties of tumors and developed a new Magnetic Resonance Imaging (MRI) technique to detect grading of tumor consistency.

Furthermore, companies are conducting clinical trials to develop new tests with high sensitivity and specificity. For instance, Laboratory for Advanced Medicine is conducting a clinical trial on 1,600 patients with liver cirrhosis using invasive biopsy through quantification of cfDNA methylation and comparing it with ultrasound technique. The test is projected to be completed in 2020.

Development and commercialization of accurate diagnostic methods is expected to boost the market. For instance, in March 2020, ENDRA Life Sciences Inc. received CE mark for TAEUS FLIP system. This system measures liver fat to identify and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH). It is an ultrasound system that accurately and at point of care quantifies fat in the liver.

Liver Disease Diagnostics Market Report Highlights:

  • The imaging segment accounted for the largest revenue share and is expected to grow at the fastest CAGR. This is attributed to the rising number of initiatives taken by key players in the liver disease diagnostics market to develop advanced imaging techniques.
  • The hospitals segment held the largest revenue share of around 45% in 2022 as the majority of patients rely on hospitals well-equipped with diagnostic testing devices.
  • North America dominated the market and accounted for the largest revenue share of over 40% in 2022 followed by Europe. High investments in R&D and the presence of key players are some factors expected to be responsible for the growth of the market for liver disease diagnostics in the region.
  • Asia Pacific is expected to grow at the fastest CAGR of 8.6% during the forecast period. Increasing geriatric population and awareness about regular check-ups are contributing to the growth of the market for liver disease diagnostics in this region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Diagnosis technique
    • 1.1.2. End use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Diagnosis technique
    • 2.2.2. End use
    • 2.2.3. Regional scope
  • 2.3. Competitive Insights

Chapter 3. Liver Disease Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Liver Disease Diagnostics Market Analysis Tools
    • 3.4.1. Industry analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Liver Disease Diagnostics: Diagnosis Technique Estimates & Trend Analysis

  • 4.1. Liver Disease Diagnostics Market: Key Takeaways
  • 4.2. Liver Disease Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Imaging
    • 4.3.1. Imaging market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Laboratory Tests
    • 4.4.1. Laboratory tests market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Endoscopy
    • 4.5.1. Endoscopy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Biopsy
    • 4.6.1. Biopsy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Liver Disease Diagnostics: End Use Estimates & Trend Analysis

  • 5.1. Liver Disease Diagnostics Market: Key Takeaways
  • 5.2. Liver Disease Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals
    • 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Laboratories
    • 5.4.1. Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Liver Disease Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Liver Disease Diagnostics Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Abbott
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. F. Hoffmann-La Roche Ltd.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Thermo Fisher Scientific Inc.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Randox Laboratories Ltd.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Boston Scientific Corporation
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Laboratory Corporation of America Holdings
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Fujifilm Corporation
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Horiba Medical
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Siemens Healthcare GmbH
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 3 North America liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 4 North America liver disease diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 6 U.S. liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 8 Canada liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 10 Europe liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe liver disease diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 13 Germany liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 14 UK liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 15 UK liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 17 France liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 19 Italy liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 21 Spain liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Sweden liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 23 Sweden liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Norway liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 25 Norway liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Denmark liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 27 Denmark liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific liver disease diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 31 China liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 32 China liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Japan liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 34 Japan liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 36 India liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Australia liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 38 Australia liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Thailand liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 40 Thailand liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 41 South Korea liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 42 South Korea liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 44 Latin America liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America liver disease diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 47 Brazil liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Mexico liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 49 Mexico liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 51 Argentina liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa liver disease diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 56 South Africa liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 60 UAE liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait liver disease diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 62 Kuwait liver disease diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Liver disease diagnostics: Market outlook
  • Fig. 9 Liver disease diagnostics: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Liver disease diagnostics market driver impact
  • Fig. 15 Liver disease diagnostics market restraint impact
  • Fig. 16 Liver disease diagnostics market strategic initiatives analysis
  • Fig. 17 Liver disease diagnostics market: Diagnosis technique movement analysis
  • Fig. 18 Liver disease diagnostics market: Diagnosis technique outlook and key takeaways
  • Fig. 19 Imaging market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Laboratory tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Endoscopy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Liver disease diagnostics market: End use movement analysis
  • Fig. 25 Liver disease diagnostics market: End use outlook and key takeaways
  • Fig. 26 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Global liver disease diagnostics market: Regional movement analysis
  • Fig. 30 Global liver disease diagnostics market: Regional outlook and key takeaways
  • Fig. 31 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)